600668.SH
尖峰集团
SSE · Basic Materials · Construction Materials · CN
CNY 7.24
−1.23%Sep 1, 2026, 07:38 UTC
Jianfeng Group's subsidiary Anhui Jianfeng Beika Pharmaceutical received approval from China's National Medical Products Administration to market the active pharmaceutical ingredient methyldopa in China.
Source:Aug 30, 2026, 07:39 UTC
Jianfeng Group announced its first-half 2026 results: main business revenue of 1.115 billion yuan, down 10.26% year-on-year; main business cost of 941 million yuan, down 1.60%; gross margin of 15.64%, down 7.43 percentage points.
Source:Jul 24, 2026, 08:11 UTC
Jianfeng Group's subsidiary Jianfeng Pharmaceutical received a Drug Registration Certificate for Tedizolid Phosphate for Injection from the National Medical Products Administration.
Source: